Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors
| Status: | Archived |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2009 |
A Phase 1, Multi-center, Open-label, Dose-escalation, Safety, Pharmacodynamic and Pharmacokinetic Study of EP-100 Given Intravenously 3 Out of 4 Weeks in Subjects With Advanced Solid Tumors
This study is being done to:
- Test the safety of EP-100 and see what effect (good and bad) it has on the patient and
their cancer;
- Find the highest dose of EP-100 that can be given without causing bad side effects;
- Examine how much EP-100 is in the blood at certain times after it is given and how
quickly the body gets rid of it;
- Observe whether there is any effect of EP-100 on the size and activity of cancer in the
patient's body.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials